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Clinical Trials Overview
Clinical Trials A clinical trial is a medical research study conducted to find answers to health questions.
Clinical trials are often conducted to evaluate new medications, a combination of medications, or new ways to use current treatments. Clinical trials are also conducted to evaluate new tests, equipment, and procedures for diagnosing and detecting health conditions and to find vaccines to prevent illnesses.
Before an experimental treatment can be tested in a clinical trial, it must have shown benefit in laboratory testing, animal research studies, or research in a small group of humans. Clinical trials are required to follow the same ethical and legal guidelines as standard medical practice to protect the safety of participants.
Every clinical trial in the United States must be approved and monitored by an Institutional Review Board (IRB) to make sure the potential risks to participants are as low as possible. Every institution that conducts clinical trials has an IRB. An IRB is a committee of health care professionals and community members that do not have connections to the specific clinical trial. The IRB committee allows for unbiased decisions to be made about the clinical trial and patient safety. Clinical Trial Informed Consent Informed consent is the process of learning about the clinical trial before deciding to participate. Before someone can participate in a clinical trial they must review and sign an informed consent form. As part of the informed consent process, participants also will be able to review the trial protocol with the clinical trial team. A clinical trial team consists of doctors, nurses, social workers, and other healthcare professionals.
Clinical Trial Eligibility
The informed consent form will include the following information:
o Clinical trial process, including tests that may be conducted o Known risks and benefits of experimental treatment o Length of clinical trial o Clinical trial contact information Even after signing the informed consent form, participants may choose to stop participating in the clinical trial at any time.
Clinical Trial Process
The process for a clinical trial depends on the type of clinical trial.
Generally, at the beginning of the clinical trial, each participant's health is checked and the team provides instructions to the participants. The team will then monitor participants closely during the clinical trial and will follow up with participants after the clinical trial is completed.
Clinical Trials Phases
Clinical trials are conducted in phases. Each phase of the clinical trial has a different purpose. o Phase 1: experimental treatment is given to a small group of people (20-80) for the first time to evaluate its safety, dosage range, and side effects o Phase 2: experimental treatment is given to a larger group of people (100-300) to evaluate its safety and effectiveness o Phase 3: experimental treatment is given to large groups of people (1,000 -3,000) to confirm its effectiveness, monitor side effects, compare to current treatments If the experimental treatment works well in a Phase 3 trial, researchers can submit an application to the U.S. Food and Drug Administration (FDA) asking permission to make the treatment available to the public. The FDA approval process generally takes about a year.
In some cases, research continues even after the FDA has approved a treatment. The FDA can ask researchers to conduct a Phase 4 trial. o Phase 4: collect information on experimental treatment's long term safety and effectiveness
Other clinical trial terms you may hear:
Placebo: A placebo is an inactive pill, liquid or powder that looks like the experimental treatment but has no effect on the body. In some clinical trials, experimental treatments are compared with placebos to evaluate the effectiveness of the experimental treatment.
Control group: A control group consists of participants who receive either standard treatment or a placebo and serves as a comparison group to measure the effectiveness of the experimental treatment other participants are receiving. Participants are randomly assigned to control or non-control groups.
Frequently Asked Questions
What are the potential benefits of participating in a clinical trial? How do I participate in a clinical trial? The first step is to talk to your doctor to see if clinical trials are an option for you.
If clinical trials are a good option for you, contact the clinical trial coordinator to see if you meet the requirements for the clinical trial.
If you meet the initial requirements, you will be scheduled for a pre-trial screening where tests will be done to help researchers decide if you are a candidate for the trial. The pre-trial screening also will be an opportunity for you to learn more about the clinical trial including its benefits and risks. Informed consent: Informed consent is the process of learning about the clinical trial before deciding whether or not to participate. There is an informed consent form that all participants are required to review and sign if they want to participate in the clinical trial. The informed consent form will include information on the clinical trial process, including tests that may be conducted, known risks and benefits of experimental treatment, length of clinical trial, and clinical trial contact information.
Institutional Review Board (IRB): An Institution Review Board (IRB) is a committee of health care professionals and community members, who review, approve, and monitor clinical trials to make sure potential risks are as low as possible and that the clinical trial follows ethical and legal codes for medical practice.
Protocol: A protocol is the clinical trial plan that explains the purpose and process of the trial. A protocol will include information such as who can participate, how many people will participate, what the treatment plan involves, type and frequency of tests, how the results will be measured, reasons why the clinical trial may be stopped, reasons why the researchers may stop giving the experimental treatment to a participant, known and likely side effects of the experimental treatment, and potential benefits of the experimental treatment.
